Ziemer adds corneal surgery to femto offering

Article

The Lamellar Corneal Surgery Module (LCS Module), with a hand-piece that can cut depths of 250?450 µm, has been released by Ziemer Group.

The Lamellar Corneal Surgery Module (LCS Module), with a hand-piece that can cut depths of 250–450 µm, has been released by Ziemer Group.

The LCS is an accessory to Ziemer's Femto LDV femtosecond surgical laser, and features a built-in camera and a graphical user interface. The Femto LDV uses high-speed and low-pulse energy and uses optics that are able to create deep stromal incisions. The addition of the LCS Module will enable highly accurate ring segment insertion, through the precisely controlled tunnel incisions and pockets the LDV can create.

Ziemer showcased the new technology on November 7 in Atlanta (Georgia, US) at the American Academy of Ophthalmology meeting.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.